Major Advance in the Treatment of Axial Spondyloarthritis Coming ...Middle East

Medscape - News
Rheumatologists can look forward to the likely regulatory approval of the oral Janus kinase inhibitors tofacitinib and upadacitinib for the treatment of axial spondyloarthritis in the first half of 2021. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Major Advance in the Treatment of Axial Spondyloarthritis Coming )

Apple Storegoogle play

Also on site :

Most viewed in News


Latest News